CLINICAL_TRIALS
trial_result
· 2013-09-18
Clinical Trial Update: Efficacy and Safety Study of IBI-10090 in Cataract Surgery Patients [Phase 2]
Summary
Phase 2 trial of IBI-10090 in ocular inflammation associated with cataract surgery was terminated; results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ICON Bioscience Inc | Conditions: Ocular Inflammation | Phase 2 | Status: TERMINATED | Results posted: 2013-09-18